Travere Therapeutics, Inc. (NASDAQ: TVTX) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On June 16, Leerink Partners analyst Joseph Schwartz reiterated the firm’s ...

Institutional investors including Armistice Capital, RTW Investments, and Wellington Management have increased their exposure ...

The FDA has removed the REMS program requirements for embryofetal toxicity risk from all endothelin receptor antagonist medications.

The list price for Filspari is around £3,400 plus VAT for a 30-day supply of tablets, but CSL Vifor is supplying the drug to the NHS at a confidential discount.

While Stifel does not view Ligand as specifically catalyst-driven, it points to the potential approval of Travere’s Filspari in FSGS with a PDUFA date of August 28, 2025, as a possible ...

Travere Therapeutics, Inc. (NASDAQ:TVTX) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On June 16, Leerink Partners analyst Joseph Schwartz reiterated the firm’s ...

In this article, we will look at the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On June 24, Jared Holz, Mizuho’s healthcare strategist, appeared on CNBC’s ‘Fast Money ...

Get the latest Travere Therapeutics, Inc. (TVTX) stock news and headlines to help you in your trading and investing decisions.

Novartis has another phase 3 trial win in its quiver for targeted factor B inhibitor iptacopan, building the case for the drug as a new oral therapy for diseases caused by disorders of the ...